Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models

被引:10
|
作者
Ujiie, Hideyuki [1 ]
Yoshimoto, Norihiro [1 ]
Natsuga, Ken [1 ]
Muramatsu, Ken [1 ]
Iwata, Hiroaki [1 ]
Nishie, Wataru [1 ]
Shimizu, Hiroshi [1 ]
机构
[1] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido, Japan
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
关键词
BP180; COL17; BP230; active mouse model; CD40; ligand; autoimmunity; autoantibody; NC18A domain; AUTOANTIBODY PROFILE; NC16A DOMAIN; BP180; ANTIGEN; DISEASE; HEMIDESMOSOME; ANTIBODIES; PROTEIN; MEMBRANE; SEVERITY;
D O I
10.3389/fimmu.2019.01410
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bullous pemphigoid (BP), the most common autoimmune blistering disease, is induced by autoantibodies to type XVII collagen (COL17). Previous studies demonstrated that COL17 harbors several epitopes targeted by autoreactive T and B cells and that the target epitopes change sequentially during the disease course. To elucidate the details of the humoral immune response to COL17, we used an active BP mouse model in which BP is induced by the adoptive transfer of spleen cells from wild-type mice immunized with human COL17-expressing skin grafting to immunodeficient COL17-humanized (Rag-2(-/-), mouse Col(17-/-), human COL17(+)) mice. By immunoblot analysis, antibodies to the NC16A domain and other extracellular domains (ECDs) of COL17 were detected earlier than antibodies to intracellular domains (ICDs) in the active BP model. Time course analysis by enzyme-linked immunosorbent assay demonstrated a delayed peak of antibodies to ICD epitopes in active BP model. The blockade of CD40-CD40 ligand interaction soon after the adoptive transfer suppressed the production of antibodies to the non-collagenous 16A (NC16A) domain but not to an ICD epitope, suggesting the sequential activation from T and B cells against the ECD epitopes including the NC16A domain to those against ICD epitopes in vivo. Both wild-type mice immunized with a fragment of the NC16A domain and the recipients of those spleen cells produced IgG antibodies to ICD and ECD epitopes, showing intramolecular epitope spreading from the NC16A domain to other epitopes of COL17. Furthermore, we found that a portion of the active BP model mice show intermolecular epitope spreading from human COL17 to murine BP230. The appearance of antibodies to ICD epitopes of COL17 or of antibodies to murine BP230 did not correlate with the skin changes in the mice, suggesting that those antibodies have low pathogenicity. These results suggest that the immune response to the ECD epitopes of COL17, especially to the NC16A domain, triggers intramolecular, and intermolecular epitope spreading to ICD epitopes of COL17 and to murine BP230. These novel findings provide insight into the mechanism of epitope spreading in organ-specific, antibody-mediated autoimmune disorders.
引用
收藏
页数:13
相关论文
共 19 条
  • [11] Autoantibodies against type XVII collagen C-terminal domain in a patient with bullous pemphigoid associated with psoriasis vulgaris
    Inokuma, D.
    Kodama, K.
    Natsuga, K.
    Kasai, M.
    Abe, M.
    Nishie, W.
    Abe, R.
    Hashimoto, T.
    Shimizu, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (02) : 451 - 454
  • [12] Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid
    Lin, Lan
    Betsuyaku, Tomoko
    Heimbach, Lisa
    Li, Ning
    Rubenstein, David
    Shapiro, Steven D.
    An, Lijia
    Giudice, George J.
    Diaz, Luis A.
    Senior, Robert M.
    Liu, Zhi
    MATRIX BIOLOGY, 2012, 31 (01) : 38 - 44
  • [13] Type XVII Collagen Regulates Lamellipod Stability, Cell Motility, and Signaling to Rac1 by Targeting Bullous Pemphigoid Antigen 1e to α6β4 Integrin
    Hamill, Kevin J.
    Hopkinson, Susan B.
    Jonkman, Marcel F.
    Jones, Jonathan C. R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (30) : 26768 - 26780
  • [14] Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2 type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa
    Darling, TN
    McGrath, JA
    Yee, C
    Gatalica, B
    Hametner, R
    Bauer, JW
    PohlaGubo, G
    Christiano, AM
    Uitto, J
    Hintner, H
    Yancey, KB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 463 - 468
  • [15] Characterization of BALB/c mice B lymphocyte autoimmune responses to skin basement membrane component type XVII collagen, the target antigen of autoimmune skin disease bullous pemphigoid
    Xu, LT
    Robinson, N
    Miller, SD
    Chan, LS
    IMMUNOLOGY LETTERS, 2001, 77 (02) : 105 - 111
  • [16] Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model
    Ujiie, Hideyuki
    Shibaki, Akihiko
    Nishie, Wataru
    Shinkuma, Satoru
    Moriuchi, Reine
    Qiao, Hongjiang
    Shimizu, Hiroshi
    CLINICAL IMMUNOLOGY, 2012, 142 (02) : 167 - 175
  • [17] A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa
    Chavanas, S
    Gache, Y
    Tadini, G
    Pulkkinen, L
    Uitto, J
    Ortonne, JP
    Meneguzzi, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (01) : 74 - 78
  • [18] Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2)
    Olivry, T
    Chan, LS
    Xu, L
    Chace, P
    Dunston, SM
    Fahey, M
    Marinkovich, MP
    VETERINARY PATHOLOGY, 1999, 36 (04) : 328 - 335
  • [19] Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
    Pigors, Manuela
    Patzelt, Sabrina
    Reichhelm, Niklas
    Dworschak, Jenny
    Khil'chenko, Stanislav
    Emtenani, Shirin
    Bieber, Katja
    Hofrichter, Maxi
    Kamaguchi, Mayumi
    Goletz, Stephanie
    Koehl, Gabriele
    Koehl, Joerg
    Komorowski, Lars
    Probst, Christian
    Vanderheyden, Katrien
    Balbino, Bianca
    Ludwig, Ralf J.
    Verheesen, Peter
    Schmidt, Enno
    JOURNAL OF PATHOLOGY, 2024, 262 (02) : 161 - 174